United States Influenza Drugs and Vaccines Market

2022-05-03
  • Detail
United States Influenza Drugs and Vaccines Market Report & Forecast 2021-2027

United States Influenza Drugs and Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)

United States Influenza Drugs and Vaccines Market Segment Percentages, By Type, 2020 (%)

- Influenza Drugs

- Influenza Vaccines

United States Influenza Drugs and Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)

United States Influenza Drugs and Vaccines Market Segment Percentages, By Application, 2020 (%)

- Hospital Pharmacy

- Retail Pharmacy

- Online Pharmacy

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Influenza Drugs and Vaccines revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Influenza Drugs and Vaccines revenues share in United States market, 2020 (%)

Key companies Influenza Drugs and Vaccines sales in United States market, 2016-2021 (Estimated), (MT)

Key companies Influenza Drugs and Vaccines sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Bristol Myers Squibb

- AstraZeneca

- Eli Lilly

- Roche

- GlaxoSmithKline

- Novartis

- Pfizer

- Sanofi Pasteur

- Bayer

- Celgene

- Seqirus

- Protein Sciences Corporation

- Serum Institute of India

- Emergent Biosolutions

- BioCryst Pharmaceuticals

- Alvogen

United States Influenza Drugs and Vaccines Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Influenza Drugs and Vaccines Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Influenza Drugs and Vaccines Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Influenza Drugs and Vaccines Overall Market Size
2.1 United States Influenza Drugs and Vaccines Market Size: 2021 VS 2027
2.2 United States Influenza Drugs and Vaccines Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Influenza Drugs and Vaccines Sales: 2016-2027
3 Company Landscape
3.1 Top Influenza Drugs and Vaccines Players in United States Market
3.2 Top United States Influenza Drugs and Vaccines Companies Ranked by Revenue
3.3 United States Influenza Drugs and Vaccines Revenue by Companies
3.4 United States Influenza Drugs and Vaccines Sales by Companies
3.5 United States Influenza Drugs and Vaccines Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Influenza Drugs and Vaccines Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Influenza Drugs and Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Influenza Drugs and Vaccines Players in United States Market
3.8.1 List of Tier 1 Influenza Drugs and Vaccines Companies in United States
3.8.2 List of Tier 2 and Tier 3 Influenza Drugs and Vaccines Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Influenza Drugs and Vaccines Market Size Markets, 2021 & 2027
4.1.2 Influenza Drugs
4.1.3 Influenza Vaccines
4.2 By Type - United States Influenza Drugs and Vaccines Revenue & Forecasts
4.2.1 By Type - United States Influenza Drugs and Vaccines Revenue, 2016-2021
4.2.2 By Type - United States Influenza Drugs and Vaccines Revenue, 2022-2027
4.2.3 By Type - United States Influenza Drugs and Vaccines Revenue Market Share, 2016-2027
4.3 By Type - United States Influenza Drugs and Vaccines Sales & Forecasts
4.3.1 By Type - United States Influenza Drugs and Vaccines Sales, 2016-2021
4.3.2 By Type - United States Influenza Drugs and Vaccines Sales, 2022-2027
4.3.3 By Type - United States Influenza Drugs and Vaccines Sales Market Share, 2016-2027
4.4 By Type - United States Influenza Drugs and Vaccines Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Influenza Drugs and Vaccines Market Size, 2021 & 2027
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.2 By Application - United States Influenza Drugs and Vaccines Revenue & Forecasts
5.2.1 By Application - United States Influenza Drugs and Vaccines Revenue, 2016-2021
5.2.2 By Application - United States Influenza Drugs and Vaccines Revenue, 2022-2027
5.2.3 By Application - United States Influenza Drugs and Vaccines Revenue Market Share, 2016-2027
5.3 By Application - United States Influenza Drugs and Vaccines Sales & Forecasts
5.3.1 By Application - United States Influenza Drugs and Vaccines Sales, 2016-2021
5.3.2 By Application - United States Influenza Drugs and Vaccines Sales, 2022-2027
5.3.3 By Application - United States Influenza Drugs and Vaccines Sales Market Share, 2016-2027
5.4 By Application - United States Influenza Drugs and Vaccines Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Corporation Information
6.1.2 Bristol Myers Squibb Overview
6.1.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.1.4 Bristol Myers Squibb Influenza Drugs and Vaccines Product Description
6.1.5 Bristol Myers Squibb Recent Developments
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Overview
6.2.3 AstraZeneca Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.2.4 AstraZeneca Influenza Drugs and Vaccines Product Description
6.2.5 AstraZeneca Recent Developments
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Overview
6.3.3 Eli Lilly Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.3.4 Eli Lilly Influenza Drugs and Vaccines Product Description
6.3.5 Eli Lilly Recent Developments
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Overview
6.4.3 Roche Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.4.4 Roche Influenza Drugs and Vaccines Product Description
6.4.5 Roche Recent Developments
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Overview
6.5.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.5.4 GlaxoSmithKline Influenza Drugs and Vaccines Product Description
6.5.5 GlaxoSmithKline Recent Developments
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Overview
6.6.3 Novartis Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.6.4 Novartis Influenza Drugs and Vaccines Product Description
6.6.5 Novartis Recent Developments
6.7 Pfizer
6.7.1 Pfizer Corporation Information
6.7.2 Pfizer Overview
6.7.3 Pfizer Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.7.4 Pfizer Influenza Drugs and Vaccines Product Description
6.7.5 Pfizer Recent Developments
6.8 Sanofi Pasteur
6.8.1 Sanofi Pasteur Corporation Information
6.8.2 Sanofi Pasteur Overview
6.8.3 Sanofi Pasteur Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.8.4 Sanofi Pasteur Influenza Drugs and Vaccines Product Description
6.8.5 Sanofi Pasteur Recent Developments
6.9 Bayer
6.9.1 Bayer Corporation Information
6.9.2 Bayer Overview
6.9.3 Bayer Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.9.4 Bayer Influenza Drugs and Vaccines Product Description
6.9.5 Bayer Recent Developments
6.10 Celgene
6.10.1 Celgene Corporation Information
6.10.2 Celgene Overview
6.10.3 Celgene Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.10.4 Celgene Influenza Drugs and Vaccines Product Description
6.10.5 Celgene Recent Developments
6.11 Seqirus
6.11.1 Seqirus Corporation Information
6.11.2 Seqirus Overview
6.11.3 Seqirus Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.11.4 Seqirus Influenza Drugs and Vaccines Product Description
6.11.5 Seqirus Recent Developments
6.12 Protein Sciences Corporation
6.12.1 Protein Sciences Corporation Corporation Information
6.12.2 Protein Sciences Corporation Overview
6.12.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.12.4 Protein Sciences Corporation Influenza Drugs and Vaccines Product Description
6.12.5 Protein Sciences Corporation Recent Developments
6.13 Serum Institute of India
6.13.1 Serum Institute of India Corporation Information
6.13.2 Serum Institute of India Overview
6.13.3 Serum Institute of India Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.13.4 Serum Institute of India Influenza Drugs and Vaccines Product Description
6.13.5 Serum Institute of India Recent Developments
6.14 Emergent Biosolutions
6.14.1 Emergent Biosolutions Corporation Information
6.14.2 Emergent Biosolutions Overview
6.14.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.14.4 Emergent Biosolutions Influenza Drugs and Vaccines Product Description
6.14.5 Emergent Biosolutions Recent Developments
6.15 BioCryst Pharmaceuticals
6.15.1 BioCryst Pharmaceuticals Corporation Information
6.15.2 BioCryst Pharmaceuticals Overview
6.15.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.15.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Description
6.15.5 BioCryst Pharmaceuticals Recent Developments
6.16 Alvogen
6.16.1 Alvogen Corporation Information
6.16.2 Alvogen Overview
6.16.3 Alvogen Influenza Drugs and Vaccines Sales and Revenue in United States Market (2016-2021)
6.16.4 Alvogen Influenza Drugs and Vaccines Product Description
6.16.5 Alvogen Recent Developments
7 United States Influenza Drugs and Vaccines Production Capacity, Analysis
7.1 United States Influenza Drugs and Vaccines Production Capacity, 2016-2027
7.2 Influenza Drugs and Vaccines Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Influenza Drugs and Vaccines Supply Chain Analysis
9.1 Influenza Drugs and Vaccines Industry Value Chain
9.2 Influenza Drugs and Vaccines Upstream Market
9.3 Influenza Drugs and Vaccines Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Influenza Drugs and Vaccines Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer

Copyright © 2011 JIN SHI